StephenAnthonyStricklandJr.MDMD, MSCI
Hematology • Nashville, TNHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Director of Leukemia Research at Sarah Cannon Research Institute
Dr. Strickland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2410 Patterson Street
Suite 500
Nashville, TN 37203Phone+1 615-342-7440- Is this information wrong?
Education & Training
Vanderbilt University School of MedicineMaster of Science in Clinical Investigation, 2007 - 2010
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008- Vanderbilt University Medical CenterResidency, Internal Medicine, 2002 - 2005
Louisiana State University School of Medicine in New OrleansClass of 2002, MD
Barry UniversityMS, Biomedical Sciences, 1995 - 1996- Louisiana State UniversityBachelors, Zoology and Physiology, 1991 - 1995
Certifications & Licensure
TN State Medical License 2005 - 2025- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML) Start of enrollment: 2008 Oct 01
- Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies Start of enrollment: 2010 Jun 10
- Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML) Start of enrollment: 2010 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsA randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.Guillermo Garcia-Manero, Nikolai A Podoltsev, Megan Othus, John M Pagel, Jerald P Radich, Min Fang, David A Rizzieri, Guido Marcucci, Stephen A Strickland, Mark R Litz...> ;Leukemia. 2024 Jan 1
- 3 citationsPI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis.Tamara K Moyo, Ashwin Kishtagari, Matthew T Villaume, Brandon McMahon, Sanjay R Mohan, Tess Stopczynski, Sheau-Chiann Chen, Run Fan, Yuankai Huo, Hyeonsoo Moon, Yuchen...> ;Clinical Cancer Research. 2023 Jul 5
- 12 citationsNorth American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, Eunice Wang, Jayastu Senapati, Nathaniel R Wilson, Marina Konopleva, Arthur E Frankel, Vikas Gupta, Ruben Mesa, Matth...> ;Blood. 2023 Feb 9
- Join now to see all
Abstracts/Posters
- Phase 3 Exploratory Analysis of Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Received Consolidation with CPX-351 ...Stephen A. Strickland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Anal...Stephen A. Strickland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Alliance A041701 - a Randomized Phase 2/3 Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia (AML) Receiving Int...Stephen A. Strickland, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Efficacy and Safety of CPX-351 Versus 7+3 in a Subgroup of Older Patients with Newly Diagnosed Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Enr...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Impact of Minimal Residual Disease and Achievement of Complete Remission/Complete Remission with Partial Hematologic Recovery (CR/CRh) on Overall Survival Following Tr...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Member
Hospital Affiliations
Vanderbilt University Medical CenterNashville, Tennessee
TriStar Centennial Medical CenterNashville, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
